Gloria V Echeverria

14PUBLICATIONS
119CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer cell biologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

|Apr 03, 2026
Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC.

Yan Jiang, Noor M Abdulkareem, Amanda L Rinkenbaugh

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Dec 09, 2024
An annotated biobank of triple negative breast cancer patient-derived xenografts featuring treatment-naïve and longitudinal samples throughout neoadjuvant chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Sep 24, 2024
Three-dimensional analysis of mitochondria in a patient-derived xenograft model of triple negative breast cancer reveals mitochondrial network remodeling following chemotherapy treatments.

Mariah J Berner, Heather K Beasley, Zer Vue

|Aug 14, 2024
Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities.

Mariah J Berner, Steven W Wall, Gloria V Echeverria

Pageof 3

Frequent Collaborators

5 joint publications

Helen Piwnica-Worms

4 joint publications

Amanda L Rinkenbaugh

4 joint publications

Jeffrey T Chang

4 joint publications

Bora Lim